Top news of the week: 13.10.2020.
Good clinical practice, Adverse event, Clinical research, OTC Bulletin Board, Vaccine, CD120
Healthcare
RT @Loner40073228: $ENZC Monoclonal Antibodies Continue to Drive Biotech Investment | Firmex Resources https://t.co/OvUJu0AfiJ
OpenMonoclonal Antibodies Continue to Drive Biotech Investment
Monoclonal antibodies represent one of the most successful therapeutic drug classes, attracting billions of investment dollars for the biotech industry.
The CRISPR Nobel was a win for all women scientists #BioTech via https://t.co/2sI0UxJbpn https://t.co/JfNotZqvzz
OpenThe CRISPR Nobel was about more than two women scientists. It was about all of them
Three CEOs who have worked with CRISPR discuss this year's Nobel Prize in chemistry, awarded to Jennifer Doudna and Emmanuelle Charpentier.
RT @HealthierIT: 4 Biotech IPOs this Week: Kronos, Shattuck, Spruce and Aziyo https://t.co/r9IJVYghk2 https://t.co/v0nx3rnvMT
Open4 Biotech IPOs this Week: Kronos, Shattuck, Spruce and Aziyo
It’s been a fairly busy week for biotech initial public offerings (IPOs) with four announcing their list pricing. Here’s a look.
Ground Zero for Covid-19 Outbreak Across US Was an International Biotech Conference in Boston Last February #BioTech via https://t.co/2sI0UxJbpn https://t.co/WSueWESu0n
OpenGround Zero for Covid-19 Outbreak Across US Was an International Biotech Conference in Boston Last February
In the “you can’t make this stuff up” and cowinkydink categories, we learn from NBC Boston that a primary superspreader event for Covid-19 spewed forth from a intonational biotech…
Bharat Biotech Asked To Give Phase-2 Data Before Phase-3 Trial Of Covid-19 Vaccine #BioTech via https://t.co/2sI0UxJbpn https://t.co/rcbBL1Piw6
OpenBharat Biotech Asked To Give Phase-2 Data Before Phase-3 Trial Of Covid-19 Vaccine
Bharat Biotech had applied to conduct Phase 3 of the human clinical trials on October 2.
Bharat Biotech asked to provide complete data of phase 2 trials #BioTech via https://t.co/2sI0UxJbpn https://t.co/9MZ8p029RG
OpenCOVID-19 vaccine: Bharat Biotech asked to provide complete data of phase 2 trials
According to sources, the phase-2 trial of the Covaxin is going on and the second dose is yet to be given to volunteers at some sites
Bharat Biotech Told To Submit Phase 2 Data Of Its Covid Vaccine Before Starting Phase 3 #BioTech via https://t.co/2sI0UxJbpn https://t.co/o3HcCk2qcx
OpenBharat Biotech Told To Submit Phase 2 Data Of Its Covid Vaccine Before Starting Phase 3: Report
Bharat Biotech, which had sought Drugs Controller General of India or DCGI's nod for conducting phase-3 clinical trials of its COVID-19 vaccine candidate, has been asked to first submit ...
4 Penny Stocks To Watch This Week As Biotech Sector Pushes Higher #BioTech #ui via https://t.co/2sI0UxJbpn https://t.co/YZsXb1HdJS
Open4 Penny Stocks To Watch This Week As Biotech Sector Pushes Higher
Are These On Your List Of Biotech Penny Stocks To Watch?